Lot Release Certificate View

Lot Release Number 2022-10-03-0273
FDA Registered Product/Generic Name DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
Brand Name INFANRIX HEXA
Dosage Strength 0.5 mL
Dosage Form SUSPENSION FOR INJECTION (I.M.) (PRESERVATIVE-FREE)
Registration Number BR-508
Batch/Lot Number A21CE145 DTPa-HBV-IPV: AC21B810A; Hib: AHIBD559A
Packaging Lot Packaging Lot (Box): A21CE145B; (Pre-filled Syringe): A21LE145B; (Vial): A21FE145B; (Needle "25G x 1"): 2105063
Product Expiration Date 30 September 2024
Issuance Date 6 October 2022